Hasil Pencarian - Megna M

Perbaiki Hasil
  1. 1
    Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study

    Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study oleh Megna M, Potestio L, Fabbrocini G, Ruggiero A

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis

    Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis oleh Potestio L, Martora F, Fabbrocini G, Battista T, Megna M

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments

    Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments oleh Battista T, Scalvenzi M, Martora F, Potestio L, Megna M

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics

    Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics oleh Ruggiero A, Portarapillo A, Megna M, Patruno C, Napolitano M

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence

    Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence oleh Ruggiero A, Picone V, Martora F, Fabbrocini G, Megna M

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature

    Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature oleh Potestio L, Ruggiero A, Fabbrocini G, Martora F, Megna M

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Herpes Zoster and COVID-19 Vaccination: A Narrative Review

    Herpes Zoster and COVID-19 Vaccination: A Narrative Review oleh Potestio L, Megna M, Villani A, Cacciapuoti S, Scalvenzi M, Martora F

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report

    Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report oleh Martora F, Battista T, Potestio L, Portarapillo A, Tommasino N, Megna M

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials

    The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials oleh Potestio L, Martora F, Lauletta G, Vallone Y, Battista T, Megna M

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study

    Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study oleh Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge

    Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge oleh Ruggiero A, Potestio L, Camela snr E, Fabbrocini G, Megna M

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]

    L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter] oleh Potestio L, Martora F, Cacciapuoti S, Megna M, Villani A, Ruggiero A

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report

    Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report oleh Martora F, Annunziata MC, Potestio L, Battista T, Ruggiero A, Megna M

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review

    Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review oleh Potestio L, Martora F, Cacciapuoti S, Megna M, Villani A, Ruggiero A

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection

    Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection oleh Potestio L, Piscitelli I, Fabbrocini G, Martora F, Ruggiero A, Megna M

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?

    Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? oleh Megna M, Camela E, Ruggiero A, Battista T, Martora F, Cacciapuoti S, Potestio L

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients’ Assessment

    Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients’ Assessment oleh Ruggiero A, Megna M, Villani A, Comune R, Fabbrocini G, di Vico F

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study

    Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study oleh Megna M, Ruggiero A, Tommasino N, Brescia C, Martora F, Cacciapuoti S, Potestio L

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Towards Personalized Medicine in Psoriasis: Current Progress

    Towards Personalized Medicine in Psoriasis: Current Progress oleh Camela E, Potestio L, Ruggiero A, Ocampo-Garza SS, Fabbrocini G, Megna M

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

    Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data oleh Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: